ArticleFrontiers in immunology2026

Pharmacovigilance analysis of infliximab in inflammatory bowel disease: novel safety signals and sex-specific adverse event profiles from the FAERS database (2004-2024).

Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.